Elliot Norry, the Chief Medical Officer of $ADAP ($ADAP), sold 5,584 shares of the company on 01-17-2025 for an estimated $3,243. We received data on the trade from a recent SEC filing. This was a sale of approximately 42.6% of their shares of this class of stock. Following this trade, they now own 7,510 shares of this class of $ADAP stock.
$ADAP Insider Trading Activity
$ADAP insiders have traded $ADAP stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $ADAP stock by insiders over the last 6 months:
- ADRIAN RAWCLIFFE (Chief Executive Officer) has made 0 purchases and 4 sales selling 90,170 shares for an estimated $52,412.
- ELLIOT NORRY (Chief Medical Officer) has made 0 purchases and 4 sales selling 27,779 shares for an estimated $16,163.
- WILLIAM C JR BERTRAND (Chief Operating Officer) has made 0 purchases and 4 sales selling 25,126 shares for an estimated $14,603.
- JOHN LUNGER (Chief Patient Supply Officer) has made 0 purchases and 4 sales selling 25,126 shares for an estimated $14,603.
- CINTIA PICCINA (Chief Commercial Officer) sold 12,991 shares for an estimated $7,467
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ADAP Hedge Fund Activity
We have seen 34 institutional investors add shares of $ADAP stock to their portfolio, and 31 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAKER BROS. ADVISORS LP removed 2,343,695 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $2,227,447
- TANG CAPITAL MANAGEMENT LLC removed 1,743,619 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $1,657,135
- BAILLIE GIFFORD & CO added 1,626,657 shares (+10.7%) to their portfolio in Q3 2024, for an estimated $1,545,974
- MATRIX CAPITAL MANAGEMENT COMPANY, LP removed 1,292,670 shares (-3.3%) from their portfolio in Q3 2024, for an estimated $1,228,553
- MORGAN STANLEY added 1,258,193 shares (+285.4%) to their portfolio in Q3 2024, for an estimated $1,195,786
- LONG FOCUS CAPITAL MANAGEMENT, LLC added 953,473 shares (+7.7%) to their portfolio in Q3 2024, for an estimated $906,180
- ACUITAS INVESTMENTS, LLC removed 541,201 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $514,357
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
